Skip to main content
SpringerLink
Log in

Endocrinologic Management of Skull Base Paraganglioma

  • Chapter
  • First Online:
Contemporary Management of Jugular Paraganglioma

  • 437 Accesses

Abstract

Although not common, the risk of associated catecholamine hypersecretion in the clinical setting of skull base paragangliomas is clinically significant. Reviewed in this chapter are the clinical presentation of patients with catecholamine-secreting tumors, case-detection testing for catecholamine hypersecretion, the role for obtaining imaging studies outside of the neck, and preoperative preparation for patients with catecholamine-secreting skull base paragangliomas .

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stenstrom G, Svardsudd K. Pheochromocytoma in Sweden 1958–1981. An analysis of the national cancer registry data. Acta Med Scand. [Research Support, Non-U.S. Gov’t]. 1986;220(3):225–32.

    Article  CAS  PubMed  Google Scholar 

  2. Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW. Secondary hypertension in a blood pressure clinic. Arch Intern Med. [Research Support, Non-U.S. Gov’t]. 1987;147(7):1289–93.

    Article  CAS  PubMed  Google Scholar 

  3. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27(3):193–202.

    Article  PubMed  Google Scholar 

  4. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. [Clinical Trial]. 2001;86(11):5210–6.

    Article  CAS  PubMed  Google Scholar 

  5. Colen TY, Mihm FG, Mason TP, Roberson JB. Catecholamine-secreting paragangliomas: recent progress in diagnosis and perioperative management. Skull Base. 2009;19(6):377–85.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Young WF Jr. Pheochromocytoma: 1926–1993. Trends Endocrinol Metab. [Clinical Conference]. 1993;4(4):122–7.

    Article  PubMed  Google Scholar 

  7. Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, et al. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab. 2005;90(4):2068–75.

    Article  CAS  PubMed  Google Scholar 

  8. Carlson ML, Sweeney AD, Pelosi S, Wanna GB, Glasscock ME 3rd, Haynes DS. Glomus tympanicum: a review of 115 cases over 4 decades. Otolaryngol Head Neck Surg. 2015;152(1):136–42.

    Article  PubMed  Google Scholar 

  9. Wanna GB, Sweeney AD, Haynes DS, Carlson ML. Contemporary management of jugular paragangliomas. Otolaryngol Clin North Am. [Review]. 2015;48(2):331–41.

    Article  PubMed  Google Scholar 

  10. Woolen S, Gemmete JJ. Paragangliomas of the head and neck. Neuroimaging Clin N Am. [Review]. 2016;26(2):259–78.

    Article  PubMed  Google Scholar 

  11. Lertakyamanee P, Srinivasan A, De Lott LB, Trobe JD. Papilledema and Vision Loss Caused by Jugular Paragangliomas. J Neuroophthalmol. [Case Reports]. 2015;35(4):364–70.

    Article  PubMed  Google Scholar 

  12. Shah VM, Prabhu V. A rare case of glomus jugulare tumor presenting as papilledema. J Neuroophthalmol. [Case Reports Letter]. 2016;36(1):110–1.

    Article  PubMed  Google Scholar 

  13. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. [Practice Guideline]. 2014;99(6):1915–42.

    Article  CAS  PubMed  Google Scholar 

  14. Young WF Jr, Maddox DE. Spells: in search of a cause. Mayo Clin Proc. [Case Reports Review]. 1995;70(8):757–65.

    Article  PubMed  Google Scholar 

  15. Kudva YC, Sawka AM, Young WF Jr. Clinical review 164: the laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. [Review]. 2003;88(10):4533–9.

    Article  CAS  PubMed  Google Scholar 

  16. Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF Jr. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol (Oxf). 2007;66(5):703–8.

    Article  CAS  Google Scholar 

  17. Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. [Review]. 2007;356(6):601–10.

    Article  CAS  PubMed  Google Scholar 

  18. Kirmani S, Young WF. Hereditary paraganglioma-pheochromocytoma syndromes. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, et al., editors. GeneReviews(R). Seattle: University of Washington; 1993.

    Google Scholar 

  19. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. [Review]. 2004;56(3):331–49.

    Article  CAS  PubMed  Google Scholar 

  20. Taylor RL, Singh RJ. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. Clin Chem. [Comparative Study]. 2002;48(3):533–9.

    CAS  PubMed  Google Scholar 

  21. Heideloff C, Payto D, Wang S. Quantitation of free metanephrines in plasma by liquid chromatography-tandem mass spectrometry. Methods Mol Biol. 2016;1378:139–47.

    Article  CAS  PubMed  Google Scholar 

  22. Gabler J, Wang S. Quantification of metanephrine and normetanephrine in urine using liquid chromatography-tandem mass spectrometry. Methods Mol Biol. 2016;1378:149–57.

    Article  CAS  PubMed  Google Scholar 

  23. Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. [Comparative Study]. 2003;88(2):553–8.

    Article  CAS  PubMed  Google Scholar 

  24. Troughton RW, Fry D, Allison RS, Nicholls MG. Depression, palpitations, and unilateral pulsatile tinnitus due to a dopamine-secreting glomus jugulare tumor. Am J Med. [Case Reports]. 1998;104(3):310–1.

    Article  CAS  PubMed  Google Scholar 

  25. Peitzsch M, Prejbisz A, Kroiss M, Beuschlein F, Arlt W, Januszewicz A, et al. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma. Ann Clin Biochem. [Research Support, Non-U.S. Gov’t]. 2013;50(Pt 2):147–55.

    CAS  PubMed  Google Scholar 

  26. Jalil ND, Pattou FN, Combemale F, Chapuis Y, Henry JF, Peix JL, et al. Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE). Eur J Surg. [Multicenter Study]. 1998;164(1):23–8.

    Article  CAS  PubMed  Google Scholar 

  27. Wiseman GA, Pacak K, O’Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, et al. Usefulness of 123I–MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med. [Evaluation Studies Multicenter Study Research Support, Non-U.S. Gov’t]. 2009;50(9):1448–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Brink I, Hoegerle S, Klisch J, Bley TA. Imaging of pheochromocytoma and paraganglioma. Fam Cancer. [Review]. 2005;4(1):61–8.

    Article  CAS  PubMed  Google Scholar 

  29. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun. [Review]. 1992;13(7):513–21.

    Article  CAS  PubMed  Google Scholar 

  30. Janssen I, Blanchet EM, Adams K, Chen CC, Millo CM, Herscovitch P, et al. Superiority of [68Ga]-DOTATATE PET/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma. Clin Cancer Res. [Research Support, N.I.H., Intramural]. 2015;21(17):3888–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Janssen I, Chen CC, Millo CM, Ling A, Taieb D, Lin FI, et al. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2016;43(10):1784–91.

    Article  CAS  PubMed  Google Scholar 

  32. Janssen I, Chen CC, Taieb D, Patronas NJ, Millo CM, Adams KT, et al. 68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT/MRI. J Nucl Med. [Research Support, N.I.H., Intramural]. 2016;57(2):186–91.

    Article  CAS  PubMed  Google Scholar 

  33. van Berkel A, Rao JU, Kusters B, Demir T, Visser E, Mensenkamp AR, et al. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma. J Nucl Med. 2014;55(8):1253–9.

    Article  PubMed  Google Scholar 

  34. Fikri AS, Kroiss A, Ahmad AZ, Zanariah H, Lau WF, Uprimny C, et al. Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F–FDG PET/CT. Acta Radiol. [Research Support, Non-U.S. Gov’t]. 2014;55(5):631–40.

    Article  PubMed  Google Scholar 

  35. Lafont M, Fagour C, Haissaguerre M, Darancette G, Wagner T, Corcuff J, et al. Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas. J Clin Endocrinol Metab. 2015;100(2):417–21.

    Article  CAS  PubMed  Google Scholar 

  36. Hariskov S, Schumann R. Intraoperative management of patients with incidental catecholamine producing tumors: a literature review and analysis. J Anaesthesiol Clin Pharmacol. 2013;29(1):41–6.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Weingarten TN, Welch TL, Moore TL, Walters GF, Whipple JL, Cavalcante A, et al. Preoperative levels of catecholamines and metanephrines and intraoperative hemodynamics of patients undergoing pheochromocytoma and paraganglioma resection. Urology. 2017;100:131–8.

    Article  PubMed  Google Scholar 

  38. Kiernan CM, Du L, Chen X, Broome JT, Shi C, Peters MF, et al. Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol. 2014;21(12):3865–71.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Sibal L, Jovanovic A, Agarwal SC, Peaston RT, James RA, Lennard TW, et al. Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clin Endocrinol (Oxf). [Case Reports]. 2006;65(2):186–90.

    Article  CAS  Google Scholar 

  40. Steinsapir J, Carr AA, Prisant LM, Bransome ED Jr. Metyrosine and pheochromocytoma. Arch Intern Med. 1997;157(8):901–6.

    Article  CAS  PubMed  Google Scholar 

  41. McBride JF, Atwell TD, Charboneau WJ, Young WF Jr, Wass TC, Callstrom MR. Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequency ablation and cryoablation therapy. J Vasc Interv Radiol. [Research Support, Non-U.S. Gov’t]. 2011;22(9):1263–70.

    Article  PubMed  Google Scholar 

  42. Brunaud L, Boutami M, Nguyen-Thi PL, Finnerty B, Germain A, Weryha G, et al. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery. 2014;156(6):1410–8.

    Article  PubMed  Google Scholar 

  43. Siddiqi HK, Yang HY, Laird AM, Fox AC, Doherty GM, Miller BS, et al. Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas. Surgery. 2012;152(6):1027–36.

    Article  PubMed  Google Scholar 

  44. Combemale F, Carnaille B, Tavernier B, Hautier MB, Thevenot A, Scherpereel P, et al. Exclusive use of calcium channel blockers and cardioselective beta-blockers in the pre- and per-operative management of pheochromocytomas. 70 cases. Ann Chir. [Clinical Trial]. 1998;52(4):341–5.

    CAS  PubMed  Google Scholar 

  45. Lebuffe G, Dosseh ED, Tek G, Tytgat H, Moreno S, Tavernier B, et al. The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia. 2005;60(5):439–44.

    Article  CAS  PubMed  Google Scholar 

  46. Jugovac I, Antapli M, Markan S. Anesthesia and pheochromocytoma. Int Anesthesiol Clin. [Case Reports]. 2011;49(2):57–61.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    William F. Young Jr. M.D., M.Sc.

Authors
  1. William F. Young Jr. M.D., M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William F. Young Jr. M.D., M.Sc. .

Editor information

Editors and Affiliations

  1. Department of Otolaryngology, Mount Sinai Health System, New York, New York, USA

    George B. Wanna

  2. Department of Otolaryngology, Mayo Clinic School of Medicine, Rochester, New York, USA

    Matthew L. Carlson

  3. Center for Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    James L. Netterville

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Young, W.F. (2018). Endocrinologic Management of Skull Base Paraganglioma. In: Wanna, G., Carlson, M., Netterville, J. (eds) Contemporary Management of Jugular Paraganglioma. Springer, Cham. https://doi.org/10.1007/978-3-319-60955-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60955-3_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-60954-6

  • Online ISBN: 978-3-319-60955-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation